Evidence map›Paper›PMID 37845333›Full record

ArticleScientific reports2023

Development and validation of a convolutional neural network to identify blepharoptosis.

Cristina Abascal Azanza, Jesús Barrio-Barrio, Jaime Ramos Cejudo, Bosco Ybarra Arróspide, Martín H Devoto

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Cristina Abascal AzanzaDepartment of Ophthalmology, Navarra Institute for Health Research (IdiSNA), Clínica Universidad de Navarra, Av. de Pío XII, 36, 31008, Pamplona, Navarra, Spain.
Jesús Barrio-BarrioDepartment of Ophthalmology, Navarra Institute for Health Research (IdiSNA), Clínica Universidad de Navarra, Av. de Pío XII, 36, 31008, Pamplona, Navarra, Spain. jbarrio@unav.es.ORCID http://orcid.org/0000-0002-0654-0249
Jaime Ramos CejudoGrossman School of Medicine, New York University (NYU, New York, USA.
Bosco Ybarra ArróspideImagine Apps, Madrid, Spain.
Martín H DevotoConsultores Oftalmologicos, Buenos Aires, Argentina.
Clinica Universidad de Navarra · ESNew York University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Blepharoptosis is a recognized cause of reversible vision loss and a non-specific indicator of neurological issues, occasionally heralding life-threatening conditions. Currently, diagnosis relies on human expertise and eyelid examination, with most existing Artificial Intelligence algorithms focusing on eyelid positioning under specialized settings. This study introduces a deep learning model with convolutional neural networks to detect blepharoptosis in more realistic conditions. Our model was trained and tested using high quality periocular images from patients with blepharoptosis as well as those with other eyelid conditions. The model achieved an area under the receiver operating characteristic curve of 0.918. For validation, we compared the model's performance against nine medical experts-oculoplastic surgeons, general ophthalmologists, and general practitioners-with varied expertise. When tested on a new dataset with varied image quality, the model's performance remained statistically comparable to that of human graders. Our findings underscore the potential to enhance telemedicine services for blepharoptosis detection.

Indexed as

Artificial IntelligenceBlepharoptosisAlgorithmsHumansNeural Networks, ComputerROC Curve

Identifiers

PMID37845333
PMCPMC10579403
OpenAlexW4387666602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.